SCHEMBL9541208

SCHEMBL9541208

CC1=C2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3CC[C@@]4(O)C#CCl)[C@@]2(C)CCC1=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.58
SHBG P04278 4/20 0.56
TSHR P16473 2/20 0.47
HIF1A Q16665 2/20 0.47
NR3C1 P04150 2/20 0.47
PGR P06401 2/20 0.47
THRB P10828 1/20 0.47
CYP2C19 P33261 1/20 0.47
MEN1 O00255 1/20 0.47
LMNA P02545 1/20 0.47
ESR1 P03372 1/20 0.47
AR P10275 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
THPO P40225 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
CYP19A1 P11511 11/20 0.46
ALDH1A1 P00352 1/20 0.41
ADRA1A P35348 1/20 0.41
HTR2B P41595 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9542845 0.90 SHBG (0.60) CYP3A4SHBGTSHRHIF1ANR3C1
SCHEMBL11520495 0.90 CYP3A4 (0.59) CYP3A4SHBGTSHRHIF1ANR3C1
SCHEMBL9542425 0.86 SHBG (0.62) CYP3A4SHBGTSHRHIF1ANR3C1
SCHEMBL11524502 0.86 SHBG (0.62) CYP3A4SHBGTSHRHIF1ANR3C1
SCHEMBL9543765 0.85 SHBG (0.41) CYP3A4SHBGTSHRHIF1ANR3C1
SCHEMBL8068247 0.84 CYP3A4 (0.56) CYP3A4SHBGTSHRHIF1ANR3C1
SCHEMBL9542574 0.82 CYP3A4 (0.67) CYP3A4SHBGTSHRHIF1ANR3C1
SCHEMBL9542566 0.82 CYP3A4 (0.67) CYP3A4SHBGTSHRHIF1ANR3C1
SCHEMBL9541880 0.80 SHBG (0.38) CYP3A4SHBGTSHRHIF1ANR3C1
SCHEMBL9541949 0.80 SHBG (0.38) CYP3A4SHBGTSHRHIF1ANR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1993013122-A1 3-METHYLSULPHONYLHYDRAZONO AND 3-OXYIMINO STEROIDS, A METHOD OF PREPARING THEM, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR USE IN THE PREPARATION OF DRUGS SCHERING AKTIENGESELLSCHAFT (DE) 1993-07-08 WO disclosed